The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117929985 11792998 5 F 20151120 20160822 20151202 20160823 EXP PHHO2015US019726 SANDOZ 6.18 YR M Y 17.90000 KG 20160824 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117929985 11792998 1 SS CTL019 TISAGENLECLEUCEL-T 1 Intravenous (not otherwise specified) TOTAL CELL DOSE: 0.3X10^9; TRANSDUCED T CELL DOSE: 3X10^6/KG 0
117929985 11792998 2 PS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown 30 MG/M2 X 4 DAYS 22137 30 MG/M**2
117929985 11792998 3 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown 500 MG/M2 X 2 DAYS 0 500 MG/M**2
117929985 11792998 4 C BACTRIM SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 41.6 MG, BID (Q SAT) 3577.6001 MG Y 0 41.6 MG BID
117929985 11792998 5 C FLUCONAZOLE. FLUCONAZOLE 1 Oral 100 MG, QD Y 0 100 MG QD
117929985 11792998 6 C LEVOFLOXACIN. LEVOFLOXACIN 1 Oral 165 MG, QD 2970 MG Y 0 165 MG QD
117929985 11792998 7 C LEVOTHYROXINE. LEVOTHYROXINE 1 Oral 37.5 UG, QD 0 37.5 UG QD
117929985 11792998 8 C ACYCLOVIR. ACYCLOVIR 1 Oral 100 MG, BID 9400 MG Y 0 100 MG BID
117929985 11792998 9 C ALLOPURINOL. ALLOPURINOL 1 Oral 60 ML, TID 456 MG Y 0 60 ML TID
117929985 11792998 10 C ALLOPURINOL. ALLOPURINOL 1 Oral 38 MG, TID 456 MG Y 0 38 MG TID
117929985 11792998 11 C IMMUNOGLOBULIN I.V HUMAN IMMUNOGLOBULIN G 1 Unknown UNK (MONTHLY/Q28 DAYS) 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117929985 11792998 1 Acute lymphocytic leukaemia
117929985 11792998 4 Antifungal prophylaxis
117929985 11792998 5 Antifungal prophylaxis
117929985 11792998 6 Antibiotic prophylaxis
117929985 11792998 7 Hypothyroidism
117929985 11792998 8 Antiviral prophylaxis
117929985 11792998 9 Prophylaxis
117929985 11792998 11 Hypogammaglobulinaemia

Outcome of event

Event ID CASEID OUTC COD
117929985 11792998 OT
117929985 11792998 LT
117929985 11792998 HO
117929985 11792998 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
117929985 11792998 Abdominal compartment syndrome
117929985 11792998 Acute kidney injury
117929985 11792998 Cytokine release syndrome
117929985 11792998 Disseminated intravascular coagulation
117929985 11792998 Febrile neutropenia
117929985 11792998 Haemorrhage intracranial
117929985 11792998 Hypotension
117929985 11792998 Hypoxia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117929985 11792998 1 20151117 20151117 0
117929985 11792998 2 20151109 20151112 0
117929985 11792998 3 20151109 20151110 0
117929985 11792998 4 20151010 20151121 0
117929985 11792998 5 20151118 20151121 0
117929985 11792998 6 20151103 20151120 0
117929985 11792998 7 20151007 0
117929985 11792998 8 20151006 20151121 0
117929985 11792998 9 20151110 0
117929985 11792998 10 20151126 20151201 0
117929985 11792998 11 20151009 0